nodes	percent_of_prediction	percent_of_DWPC	metapath
Butabarbital—CHRFAM7A—ovarian follicle—hematologic cancer	0.0853	0.382	CbGeAlD
Butabarbital—CHRNA7—ovarian follicle—hematologic cancer	0.0689	0.308	CbGeAlD
Butabarbital—CHRFAM7A—hematopoietic system—hematologic cancer	0.0103	0.0461	CbGeAlD
Butabarbital—CHRNA7—hematopoietic system—hematologic cancer	0.00831	0.0372	CbGeAlD
Butabarbital—CHRNA4—hematopoietic system—hematologic cancer	0.0082	0.0367	CbGeAlD
Butabarbital—CHRFAM7A—blood—hematologic cancer	0.00682	0.0305	CbGeAlD
Butabarbital—GRIA2—testis—hematologic cancer	0.00619	0.0277	CbGeAlD
Butabarbital—CHRFAM7A—testis—hematologic cancer	0.00564	0.0252	CbGeAlD
Butabarbital—CHRNA7—blood—hematologic cancer	0.00551	0.0246	CbGeAlD
Butabarbital—CHRNA4—lung—hematologic cancer	0.00476	0.0213	CbGeAlD
Butabarbital—GABRB2—lung—hematologic cancer	0.00467	0.0209	CbGeAlD
Butabarbital—CHRNA7—testis—hematologic cancer	0.00456	0.0204	CbGeAlD
Butabarbital—GABRB2—testis—hematologic cancer	0.0044	0.0197	CbGeAlD
Butabarbital—Dizziness—Hydroxyurea—hematologic cancer	0.000545	0.000816	CcSEcCtD
Butabarbital—Feeling abnormal—Alitretinoin—hematologic cancer	0.000544	0.000814	CcSEcCtD
Butabarbital—Constipation—Vincristine—hematologic cancer	0.000544	0.000814	CcSEcCtD
Butabarbital—Rash—Melphalan—hematologic cancer	0.000542	0.000811	CcSEcCtD
Butabarbital—Dermatitis—Melphalan—hematologic cancer	0.000541	0.00081	CcSEcCtD
Butabarbital—Feeling abnormal—Ifosfamide—hematologic cancer	0.000537	0.000804	CcSEcCtD
Butabarbital—Nausea—Vinblastine—hematologic cancer	0.000537	0.000803	CcSEcCtD
Butabarbital—Somnolence—Gemcitabine—hematologic cancer	0.000536	0.000803	CcSEcCtD
Butabarbital—Vomiting—Lenalidomide—hematologic cancer	0.000531	0.000795	CcSEcCtD
Butabarbital—Constipation—Irinotecan—hematologic cancer	0.00053	0.000793	CcSEcCtD
Butabarbital—Constipation—Mitoxantrone—hematologic cancer	0.00053	0.000793	CcSEcCtD
Butabarbital—Bradycardia—Prednisone—hematologic cancer	0.000529	0.000792	CcSEcCtD
Butabarbital—Hypersensitivity—Thiotepa—hematologic cancer	0.000528	0.000791	CcSEcCtD
Butabarbital—Rash—Lenalidomide—hematologic cancer	0.000527	0.000789	CcSEcCtD
Butabarbital—Body temperature increased—Carmustine—hematologic cancer	0.000527	0.000788	CcSEcCtD
Butabarbital—Dermatitis—Lenalidomide—hematologic cancer	0.000526	0.000788	CcSEcCtD
Butabarbital—Hypotension—Cisplatin—hematologic cancer	0.000525	0.000786	CcSEcCtD
Butabarbital—Vomiting—Hydroxyurea—hematologic cancer	0.000524	0.000784	CcSEcCtD
Butabarbital—Headache—Lenalidomide—hematologic cancer	0.000524	0.000784	CcSEcCtD
Butabarbital—Angioedema—Triamcinolone—hematologic cancer	0.000523	0.000783	CcSEcCtD
Butabarbital—Body temperature increased—Alitretinoin—hematologic cancer	0.000522	0.000781	CcSEcCtD
Butabarbital—Rash—Hydroxyurea—hematologic cancer	0.00052	0.000778	CcSEcCtD
Butabarbital—Confusional state—Etoposide—hematologic cancer	0.000519	0.000777	CcSEcCtD
Butabarbital—Dermatitis—Hydroxyurea—hematologic cancer	0.000519	0.000777	CcSEcCtD
Butabarbital—Hallucination—Prednisone—hematologic cancer	0.000517	0.000774	CcSEcCtD
Butabarbital—Headache—Hydroxyurea—hematologic cancer	0.000516	0.000773	CcSEcCtD
Butabarbital—Constipation—Gemcitabine—hematologic cancer	0.000516	0.000772	CcSEcCtD
Butabarbital—Body temperature increased—Ifosfamide—hematologic cancer	0.000516	0.000772	CcSEcCtD
Butabarbital—Syncope—Triamcinolone—hematologic cancer	0.000513	0.000768	CcSEcCtD
Butabarbital—Ataxia—Doxorubicin—hematologic cancer	0.000511	0.000765	CcSEcCtD
Butabarbital—Hypersensitivity—Thalidomide—hematologic cancer	0.000511	0.000765	CcSEcCtD
Butabarbital—Nausea—Melphalan—hematologic cancer	0.000511	0.000764	CcSEcCtD
Butabarbital—Feeling abnormal—Mitoxantrone—hematologic cancer	0.00051	0.000764	CcSEcCtD
Butabarbital—Feeling abnormal—Irinotecan—hematologic cancer	0.00051	0.000764	CcSEcCtD
Butabarbital—Dizziness—Bortezomib—hematologic cancer	0.000509	0.000761	CcSEcCtD
Butabarbital—Loss of consciousness—Triamcinolone—hematologic cancer	0.000503	0.000753	CcSEcCtD
Butabarbital—Body temperature increased—Vincristine—hematologic cancer	0.000503	0.000752	CcSEcCtD
Butabarbital—Shock—Prednisolone—hematologic cancer	0.0005	0.000748	CcSEcCtD
Butabarbital—Feeling abnormal—Gemcitabine—hematologic cancer	0.000497	0.000744	CcSEcCtD
Butabarbital—Dizziness—Vinorelbine—hematologic cancer	0.000497	0.000743	CcSEcCtD
Butabarbital—Nausea—Lenalidomide—hematologic cancer	0.000496	0.000743	CcSEcCtD
Butabarbital—Hypersensitivity—Carmustine—hematologic cancer	0.000491	0.000735	CcSEcCtD
Butabarbital—Body temperature increased—Irinotecan—hematologic cancer	0.00049	0.000733	CcSEcCtD
Butabarbital—Body temperature increased—Mitoxantrone—hematologic cancer	0.00049	0.000733	CcSEcCtD
Butabarbital—Nausea—Hydroxyurea—hematologic cancer	0.000489	0.000733	CcSEcCtD
Butabarbital—Vomiting—Bortezomib—hematologic cancer	0.000489	0.000732	CcSEcCtD
Butabarbital—Hypersensitivity—Alitretinoin—hematologic cancer	0.000486	0.000728	CcSEcCtD
Butabarbital—Vomiting—Bleomycin—hematologic cancer	0.000485	0.000726	CcSEcCtD
Butabarbital—Rash—Bortezomib—hematologic cancer	0.000485	0.000726	CcSEcCtD
Butabarbital—Dermatitis—Bortezomib—hematologic cancer	0.000484	0.000725	CcSEcCtD
Butabarbital—Headache—Bortezomib—hematologic cancer	0.000482	0.000721	CcSEcCtD
Butabarbital—Hypotension—Etoposide—hematologic cancer	0.000481	0.00072	CcSEcCtD
Butabarbital—Rash—Bleomycin—hematologic cancer	0.000481	0.00072	CcSEcCtD
Butabarbital—Dermatitis—Bleomycin—hematologic cancer	0.000481	0.00072	CcSEcCtD
Butabarbital—Hypersensitivity—Ifosfamide—hematologic cancer	0.000481	0.000719	CcSEcCtD
Butabarbital—Vomiting—Vinorelbine—hematologic cancer	0.000477	0.000715	CcSEcCtD
Butabarbital—Body temperature increased—Gemcitabine—hematologic cancer	0.000477	0.000714	CcSEcCtD
Butabarbital—Angioedema—Betamethasone—hematologic cancer	0.000475	0.00071	CcSEcCtD
Butabarbital—Angioedema—Dexamethasone—hematologic cancer	0.000475	0.00071	CcSEcCtD
Butabarbital—Dizziness—Thiotepa—hematologic cancer	0.000474	0.00071	CcSEcCtD
Butabarbital—Rash—Vinorelbine—hematologic cancer	0.000473	0.000709	CcSEcCtD
Butabarbital—Dermatitis—Vinorelbine—hematologic cancer	0.000473	0.000708	CcSEcCtD
Butabarbital—Headache—Vinorelbine—hematologic cancer	0.00047	0.000704	CcSEcCtD
Butabarbital—Hypersensitivity—Vincristine—hematologic cancer	0.000468	0.000701	CcSEcCtD
Butabarbital—Syncope—Betamethasone—hematologic cancer	0.000466	0.000697	CcSEcCtD
Butabarbital—Syncope—Dexamethasone—hematologic cancer	0.000466	0.000697	CcSEcCtD
Butabarbital—Feeling abnormal—Cisplatin—hematologic cancer	0.000463	0.000694	CcSEcCtD
Butabarbital—Shock—Triamcinolone—hematologic cancer	0.00046	0.000688	CcSEcCtD
Butabarbital—Dizziness—Thalidomide—hematologic cancer	0.000459	0.000686	CcSEcCtD
Butabarbital—Somnolence—Etoposide—hematologic cancer	0.000458	0.000685	CcSEcCtD
Butabarbital—Nausea—Bortezomib—hematologic cancer	0.000457	0.000684	CcSEcCtD
Butabarbital—Loss of consciousness—Betamethasone—hematologic cancer	0.000457	0.000683	CcSEcCtD
Butabarbital—Loss of consciousness—Dexamethasone—hematologic cancer	0.000457	0.000683	CcSEcCtD
Butabarbital—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000456	0.000683	CcSEcCtD
Butabarbital—Hypersensitivity—Irinotecan—hematologic cancer	0.000456	0.000683	CcSEcCtD
Butabarbital—Vomiting—Thiotepa—hematologic cancer	0.000456	0.000682	CcSEcCtD
Butabarbital—Nausea—Bleomycin—hematologic cancer	0.000453	0.000678	CcSEcCtD
Butabarbital—Rash—Thiotepa—hematologic cancer	0.000452	0.000677	CcSEcCtD
Butabarbital—Dermatitis—Thiotepa—hematologic cancer	0.000452	0.000676	CcSEcCtD
Butabarbital—Headache—Thiotepa—hematologic cancer	0.000449	0.000672	CcSEcCtD
Butabarbital—Nausea—Vinorelbine—hematologic cancer	0.000446	0.000668	CcSEcCtD
Butabarbital—Body temperature increased—Cisplatin—hematologic cancer	0.000444	0.000665	CcSEcCtD
Butabarbital—Vomiting—Thalidomide—hematologic cancer	0.000441	0.00066	CcSEcCtD
Butabarbital—Anxiety—Dexamethasone—hematologic cancer	0.000441	0.00066	CcSEcCtD
Butabarbital—Anxiety—Betamethasone—hematologic cancer	0.000441	0.00066	CcSEcCtD
Butabarbital—Dizziness—Carmustine—hematologic cancer	0.00044	0.000659	CcSEcCtD
Butabarbital—Constipation—Etoposide—hematologic cancer	0.00044	0.000659	CcSEcCtD
Butabarbital—Rash—Thalidomide—hematologic cancer	0.000437	0.000655	CcSEcCtD
Butabarbital—Dermatitis—Thalidomide—hematologic cancer	0.000437	0.000654	CcSEcCtD
Butabarbital—Dizziness—Alitretinoin—hematologic cancer	0.000436	0.000653	CcSEcCtD
Butabarbital—Headache—Thalidomide—hematologic cancer	0.000435	0.00065	CcSEcCtD
Butabarbital—Dizziness—Ifosfamide—hematologic cancer	0.000431	0.000646	CcSEcCtD
Butabarbital—Nausea—Thiotepa—hematologic cancer	0.000426	0.000638	CcSEcCtD
Butabarbital—Feeling abnormal—Etoposide—hematologic cancer	0.000424	0.000635	CcSEcCtD
Butabarbital—Vomiting—Carmustine—hematologic cancer	0.000424	0.000634	CcSEcCtD
Butabarbital—Dizziness—Vincristine—hematologic cancer	0.00042	0.000629	CcSEcCtD
Butabarbital—Rash—Carmustine—hematologic cancer	0.00042	0.000629	CcSEcCtD
Butabarbital—Dermatitis—Carmustine—hematologic cancer	0.00042	0.000628	CcSEcCtD
Butabarbital—Vomiting—Alitretinoin—hematologic cancer	0.00042	0.000628	CcSEcCtD
Butabarbital—Feeling abnormal—Prednisolone—hematologic cancer	0.000419	0.000627	CcSEcCtD
Butabarbital—Headache—Carmustine—hematologic cancer	0.000417	0.000625	CcSEcCtD
Butabarbital—Shock—Dexamethasone—hematologic cancer	0.000417	0.000624	CcSEcCtD
Butabarbital—Shock—Betamethasone—hematologic cancer	0.000417	0.000624	CcSEcCtD
Butabarbital—Rash—Alitretinoin—hematologic cancer	0.000416	0.000623	CcSEcCtD
Butabarbital—Agitation—Prednisone—hematologic cancer	0.000416	0.000622	CcSEcCtD
Butabarbital—Dermatitis—Alitretinoin—hematologic cancer	0.000416	0.000622	CcSEcCtD
Butabarbital—Vomiting—Ifosfamide—hematologic cancer	0.000415	0.000621	CcSEcCtD
Butabarbital—Hypersensitivity—Cisplatin—hematologic cancer	0.000414	0.00062	CcSEcCtD
Butabarbital—Bradycardia—Epirubicin—hematologic cancer	0.000414	0.000619	CcSEcCtD
Butabarbital—Headache—Alitretinoin—hematologic cancer	0.000413	0.000619	CcSEcCtD
Butabarbital—Angioedema—Prednisone—hematologic cancer	0.000413	0.000619	CcSEcCtD
Butabarbital—Nausea—Thalidomide—hematologic cancer	0.000412	0.000617	CcSEcCtD
Butabarbital—Rash—Ifosfamide—hematologic cancer	0.000411	0.000616	CcSEcCtD
Butabarbital—Dermatitis—Ifosfamide—hematologic cancer	0.000411	0.000615	CcSEcCtD
Butabarbital—Dizziness—Irinotecan—hematologic cancer	0.00041	0.000613	CcSEcCtD
Butabarbital—Body temperature increased—Etoposide—hematologic cancer	0.000407	0.000609	CcSEcCtD
Butabarbital—Syncope—Prednisone—hematologic cancer	0.000406	0.000607	CcSEcCtD
Butabarbital—Vomiting—Vincristine—hematologic cancer	0.000404	0.000605	CcSEcCtD
Butabarbital—Rash—Vincristine—hematologic cancer	0.000401	0.0006	CcSEcCtD
Butabarbital—Dermatitis—Vincristine—hematologic cancer	0.000401	0.0006	CcSEcCtD
Butabarbital—Headache—Vincristine—hematologic cancer	0.000398	0.000596	CcSEcCtD
Butabarbital—Loss of consciousness—Prednisone—hematologic cancer	0.000398	0.000595	CcSEcCtD
Butabarbital—Hypotension—Betamethasone—hematologic cancer	0.000396	0.000593	CcSEcCtD
Butabarbital—Hypotension—Dexamethasone—hematologic cancer	0.000396	0.000593	CcSEcCtD
Butabarbital—Nausea—Carmustine—hematologic cancer	0.000396	0.000592	CcSEcCtD
Butabarbital—Vomiting—Irinotecan—hematologic cancer	0.000394	0.000589	CcSEcCtD
Butabarbital—Vomiting—Mitoxantrone—hematologic cancer	0.000394	0.000589	CcSEcCtD
Butabarbital—Nausea—Alitretinoin—hematologic cancer	0.000392	0.000587	CcSEcCtD
Butabarbital—Rash—Irinotecan—hematologic cancer	0.00039	0.000584	CcSEcCtD
Butabarbital—Rash—Mitoxantrone—hematologic cancer	0.00039	0.000584	CcSEcCtD
Butabarbital—Dermatitis—Mitoxantrone—hematologic cancer	0.00039	0.000584	CcSEcCtD
Butabarbital—Dermatitis—Irinotecan—hematologic cancer	0.00039	0.000584	CcSEcCtD
Butabarbital—Headache—Irinotecan—hematologic cancer	0.000388	0.000581	CcSEcCtD
Butabarbital—Headache—Mitoxantrone—hematologic cancer	0.000388	0.000581	CcSEcCtD
Butabarbital—Nausea—Ifosfamide—hematologic cancer	0.000387	0.00058	CcSEcCtD
Butabarbital—Feeling abnormal—Triamcinolone—hematologic cancer	0.000385	0.000576	CcSEcCtD
Butabarbital—Anxiety—Prednisone—hematologic cancer	0.000384	0.000574	CcSEcCtD
Butabarbital—Vomiting—Gemcitabine—hematologic cancer	0.000384	0.000574	CcSEcCtD
Butabarbital—Bradycardia—Doxorubicin—hematologic cancer	0.000383	0.000573	CcSEcCtD
Butabarbital—Rash—Gemcitabine—hematologic cancer	0.00038	0.000569	CcSEcCtD
Butabarbital—Dermatitis—Gemcitabine—hematologic cancer	0.00038	0.000569	CcSEcCtD
Butabarbital—Hypersensitivity—Etoposide—hematologic cancer	0.00038	0.000568	CcSEcCtD
Butabarbital—Headache—Gemcitabine—hematologic cancer	0.000378	0.000566	CcSEcCtD
Butabarbital—Nausea—Vincristine—hematologic cancer	0.000378	0.000565	CcSEcCtD
Butabarbital—Hypersensitivity—Prednisolone—hematologic cancer	0.000374	0.00056	CcSEcCtD
Butabarbital—Body temperature increased—Triamcinolone—hematologic cancer	0.000369	0.000553	CcSEcCtD
Butabarbital—Nausea—Irinotecan—hematologic cancer	0.000368	0.000551	CcSEcCtD
Butabarbital—Nausea—Mitoxantrone—hematologic cancer	0.000368	0.000551	CcSEcCtD
Butabarbital—Shock—Prednisone—hematologic cancer	0.000363	0.000544	CcSEcCtD
Butabarbital—Nausea—Gemcitabine—hematologic cancer	0.000358	0.000536	CcSEcCtD
Butabarbital—Vomiting—Cisplatin—hematologic cancer	0.000357	0.000535	CcSEcCtD
Butabarbital—Rash—Cisplatin—hematologic cancer	0.000355	0.000531	CcSEcCtD
Butabarbital—Dermatitis—Cisplatin—hematologic cancer	0.000354	0.00053	CcSEcCtD
Butabarbital—Feeling abnormal—Dexamethasone—hematologic cancer	0.000349	0.000523	CcSEcCtD
Butabarbital—Feeling abnormal—Betamethasone—hematologic cancer	0.000349	0.000523	CcSEcCtD
Butabarbital—Tension—Epirubicin—hematologic cancer	0.000347	0.00052	CcSEcCtD
Butabarbital—Hypersensitivity—Triamcinolone—hematologic cancer	0.000344	0.000515	CcSEcCtD
Butabarbital—Nervousness—Epirubicin—hematologic cancer	0.000344	0.000514	CcSEcCtD
Butabarbital—Dizziness—Etoposide—hematologic cancer	0.000341	0.00051	CcSEcCtD
Butabarbital—Dizziness—Prednisolone—hematologic cancer	0.000336	0.000503	CcSEcCtD
Butabarbital—Body temperature increased—Dexamethasone—hematologic cancer	0.000335	0.000502	CcSEcCtD
Butabarbital—Body temperature increased—Betamethasone—hematologic cancer	0.000335	0.000502	CcSEcCtD
Butabarbital—Nausea—Cisplatin—hematologic cancer	0.000334	0.0005	CcSEcCtD
Butabarbital—Vomiting—Etoposide—hematologic cancer	0.000328	0.00049	CcSEcCtD
Butabarbital—Agitation—Epirubicin—hematologic cancer	0.000325	0.000487	CcSEcCtD
Butabarbital—Rash—Etoposide—hematologic cancer	0.000325	0.000486	CcSEcCtD
Butabarbital—Dermatitis—Etoposide—hematologic cancer	0.000324	0.000486	CcSEcCtD
Butabarbital—Headache—Etoposide—hematologic cancer	0.000323	0.000483	CcSEcCtD
Butabarbital—Tension—Doxorubicin—hematologic cancer	0.000321	0.000481	CcSEcCtD
Butabarbital—Rash—Prednisolone—hematologic cancer	0.00032	0.000479	CcSEcCtD
Butabarbital—Dermatitis—Prednisolone—hematologic cancer	0.00032	0.000479	CcSEcCtD
Butabarbital—Headache—Prednisolone—hematologic cancer	0.000318	0.000476	CcSEcCtD
Butabarbital—Nervousness—Doxorubicin—hematologic cancer	0.000318	0.000476	CcSEcCtD
Butabarbital—Syncope—Epirubicin—hematologic cancer	0.000317	0.000475	CcSEcCtD
Butabarbital—Constipation—Prednisone—hematologic cancer	0.000316	0.000473	CcSEcCtD
Butabarbital—Confusional state—Methotrexate—hematologic cancer	0.000311	0.000466	CcSEcCtD
Butabarbital—Loss of consciousness—Epirubicin—hematologic cancer	0.000311	0.000465	CcSEcCtD
Butabarbital—Dizziness—Triamcinolone—hematologic cancer	0.000309	0.000462	CcSEcCtD
Butabarbital—Nausea—Etoposide—hematologic cancer	0.000306	0.000458	CcSEcCtD
Butabarbital—Feeling abnormal—Prednisone—hematologic cancer	0.000304	0.000455	CcSEcCtD
Butabarbital—Nausea—Prednisolone—hematologic cancer	0.000302	0.000452	CcSEcCtD
Butabarbital—Agitation—Doxorubicin—hematologic cancer	0.000301	0.00045	CcSEcCtD
Butabarbital—Anxiety—Epirubicin—hematologic cancer	0.0003	0.000449	CcSEcCtD
Butabarbital—Vomiting—Triamcinolone—hematologic cancer	0.000297	0.000445	CcSEcCtD
Butabarbital—Rash—Triamcinolone—hematologic cancer	0.000295	0.000441	CcSEcCtD
Butabarbital—Dermatitis—Triamcinolone—hematologic cancer	0.000294	0.000441	CcSEcCtD
Butabarbital—Syncope—Doxorubicin—hematologic cancer	0.000294	0.000439	CcSEcCtD
Butabarbital—Headache—Triamcinolone—hematologic cancer	0.000293	0.000438	CcSEcCtD
Butabarbital—Body temperature increased—Prednisone—hematologic cancer	0.000292	0.000437	CcSEcCtD
Butabarbital—Confusional state—Epirubicin—hematologic cancer	0.000291	0.000436	CcSEcCtD
Butabarbital—Hypotension—Methotrexate—hematologic cancer	0.000288	0.000432	CcSEcCtD
Butabarbital—Loss of consciousness—Doxorubicin—hematologic cancer	0.000288	0.000431	CcSEcCtD
Butabarbital—Shock—Epirubicin—hematologic cancer	0.000284	0.000425	CcSEcCtD
Butabarbital—Dizziness—Betamethasone—hematologic cancer	0.00028	0.00042	CcSEcCtD
Butabarbital—Dizziness—Dexamethasone—hematologic cancer	0.00028	0.00042	CcSEcCtD
Butabarbital—GRIA2—Neuronal System—ADCY7—hematologic cancer	0.00028	0.00258	CbGpPWpGaD
Butabarbital—Anxiety—Doxorubicin—hematologic cancer	0.000278	0.000416	CcSEcCtD
Butabarbital—Nausea—Triamcinolone—hematologic cancer	0.000278	0.000415	CcSEcCtD
Butabarbital—GABRB2—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.000276	0.00255	CbGpPWpGaD
Butabarbital—Somnolence—Methotrexate—hematologic cancer	0.000274	0.000411	CcSEcCtD
Butabarbital—GABRB2—Transmission across Chemical Synapses—ADCY7—hematologic cancer	0.000274	0.00253	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—SLC22A1—hematologic cancer	0.000274	0.00253	CbGpPWpGaD
Butabarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCG—hematologic cancer	0.000273	0.00252	CbGpPWpGaD
Butabarbital—Hypersensitivity—Prednisone—hematologic cancer	0.000272	0.000407	CcSEcCtD
Butabarbital—GABRG2—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.000272	0.00251	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—ADCY7—hematologic cancer	0.000271	0.0025	CbGpPWpGaD
Butabarbital—Hypotension—Epirubicin—hematologic cancer	0.00027	0.000404	CcSEcCtD
Butabarbital—Vomiting—Dexamethasone—hematologic cancer	0.00027	0.000403	CcSEcCtD
Butabarbital—Vomiting—Betamethasone—hematologic cancer	0.00027	0.000403	CcSEcCtD
Butabarbital—Confusional state—Doxorubicin—hematologic cancer	0.000269	0.000403	CcSEcCtD
Butabarbital—GABRA1—Orphan transporters—CYCS—hematologic cancer	0.000269	0.00248	CbGpPWpGaD
Butabarbital—GRIK2—Transmission across Chemical Synapses—PRKCG—hematologic cancer	0.000269	0.00248	CbGpPWpGaD
Butabarbital—Rash—Betamethasone—hematologic cancer	0.000267	0.0004	CcSEcCtD
Butabarbital—Rash—Dexamethasone—hematologic cancer	0.000267	0.0004	CcSEcCtD
Butabarbital—Dermatitis—Betamethasone—hematologic cancer	0.000267	0.0004	CcSEcCtD
Butabarbital—Dermatitis—Dexamethasone—hematologic cancer	0.000267	0.0004	CcSEcCtD
Butabarbital—Headache—Betamethasone—hematologic cancer	0.000266	0.000398	CcSEcCtD
Butabarbital—Headache—Dexamethasone—hematologic cancer	0.000266	0.000398	CcSEcCtD
Butabarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCG—hematologic cancer	0.000265	0.00244	CbGpPWpGaD
Butabarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—hematologic cancer	0.000265	0.00244	CbGpPWpGaD
Butabarbital—Shock—Doxorubicin—hematologic cancer	0.000263	0.000393	CcSEcCtD
Butabarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—hematologic cancer	0.000261	0.00241	CbGpPWpGaD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—hematologic cancer	0.000259	0.00239	CbGpPWpGaD
Butabarbital—Somnolence—Epirubicin—hematologic cancer	0.000257	0.000384	CcSEcCtD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—HES1—hematologic cancer	0.000256	0.00236	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—IL10—hematologic cancer	0.000255	0.00235	CbGpPWpGaD
Butabarbital—Feeling abnormal—Methotrexate—hematologic cancer	0.000254	0.000381	CcSEcCtD
Butabarbital—GABRG2—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.000252	0.00233	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—IL13—hematologic cancer	0.000252	0.00232	CbGpPWpGaD
Butabarbital—Nausea—Betamethasone—hematologic cancer	0.000252	0.000377	CcSEcCtD
Butabarbital—Nausea—Dexamethasone—hematologic cancer	0.000252	0.000377	CcSEcCtD
Butabarbital—GABRG2—Transmission across Chemical Synapses—ADCY7—hematologic cancer	0.000251	0.00231	CbGpPWpGaD
Butabarbital—Hypotension—Doxorubicin—hematologic cancer	0.00025	0.000374	CcSEcCtD
Butabarbital—GRIA2—Neuronal System—CAMK2D—hematologic cancer	0.000249	0.0023	CbGpPWpGaD
Butabarbital—Constipation—Epirubicin—hematologic cancer	0.000247	0.00037	CcSEcCtD
Butabarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—hematologic cancer	0.000245	0.00226	CbGpPWpGaD
Butabarbital—CHRNA7—Transmission across Chemical Synapses—PRKCG—hematologic cancer	0.000244	0.00225	CbGpPWpGaD
Butabarbital—Dizziness—Prednisone—hematologic cancer	0.000244	0.000365	CcSEcCtD
Butabarbital—GABRB2—Transmission across Chemical Synapses—CAMK2D—hematologic cancer	0.000244	0.00225	CbGpPWpGaD
Butabarbital—Body temperature increased—Methotrexate—hematologic cancer	0.000244	0.000365	CcSEcCtD
Butabarbital—CHRNA4—Neuronal System—CAMK2D—hematologic cancer	0.000241	0.00223	CbGpPWpGaD
Butabarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—hematologic cancer	0.000241	0.00222	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—SLC22A1—hematologic cancer	0.000239	0.00221	CbGpPWpGaD
Butabarbital—Feeling abnormal—Epirubicin—hematologic cancer	0.000238	0.000356	CcSEcCtD
Butabarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—hematologic cancer	0.000238	0.00219	CbGpPWpGaD
Butabarbital—Somnolence—Doxorubicin—hematologic cancer	0.000238	0.000356	CcSEcCtD
Butabarbital—GABRA1—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.000237	0.00219	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—NR3C1—hematologic cancer	0.000236	0.00217	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—TSC2—hematologic cancer	0.000235	0.00217	CbGpPWpGaD
Butabarbital—Vomiting—Prednisone—hematologic cancer	0.000235	0.000351	CcSEcCtD
Butabarbital—Rash—Prednisone—hematologic cancer	0.000233	0.000348	CcSEcCtD
Butabarbital—Dermatitis—Prednisone—hematologic cancer	0.000233	0.000348	CcSEcCtD
Butabarbital—Headache—Prednisone—hematologic cancer	0.000231	0.000346	CcSEcCtD
Butabarbital—GABRB2—Neuronal System—SLC22A1—hematologic cancer	0.000229	0.00212	CbGpPWpGaD
Butabarbital—Constipation—Doxorubicin—hematologic cancer	0.000228	0.000342	CcSEcCtD
Butabarbital—Body temperature increased—Epirubicin—hematologic cancer	0.000228	0.000342	CcSEcCtD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—GATA3—hematologic cancer	0.000227	0.0021	CbGpPWpGaD
Butabarbital—Hypersensitivity—Methotrexate—hematologic cancer	0.000227	0.00034	CcSEcCtD
Butabarbital—GABRB2—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.000225	0.00208	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—MAPK14—hematologic cancer	0.000224	0.00207	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—CAMK2D—hematologic cancer	0.000223	0.00206	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—CREB1—hematologic cancer	0.000221	0.00204	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.000221	0.00204	CbGpPWpGaD
Butabarbital—Feeling abnormal—Doxorubicin—hematologic cancer	0.00022	0.00033	CcSEcCtD
Butabarbital—Nausea—Prednisone—hematologic cancer	0.000219	0.000328	CcSEcCtD
Butabarbital—GABRA1—Transmission across Chemical Synapses—ADCY7—hematologic cancer	0.000219	0.00202	CbGpPWpGaD
Butabarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—hematologic cancer	0.000219	0.00202	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—IL6R—hematologic cancer	0.000215	0.00199	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—CREBBP—hematologic cancer	0.000215	0.00198	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—BAD—hematologic cancer	0.000215	0.00198	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—NFKBIA—hematologic cancer	0.000215	0.00198	CbGpPWpGaD
Butabarbital—Hypersensitivity—Epirubicin—hematologic cancer	0.000213	0.000318	CcSEcCtD
Butabarbital—Body temperature increased—Doxorubicin—hematologic cancer	0.000211	0.000316	CcSEcCtD
Butabarbital—GABRB2—Neuronal System—ADCY7—hematologic cancer	0.00021	0.00194	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—SLC22A1—hematologic cancer	0.00021	0.00193	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.000209	0.00193	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.000206	0.0019	CbGpPWpGaD
Butabarbital—GRIK2—Neuronal System—PRKCG—hematologic cancer	0.000206	0.0019	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—PRKCG—hematologic cancer	0.000205	0.00189	CbGpPWpGaD
Butabarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCG—hematologic cancer	0.000205	0.00189	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—PTPN11—hematologic cancer	0.000204	0.00188	CbGpPWpGaD
Butabarbital—Dizziness—Methotrexate—hematologic cancer	0.000204	0.000305	CcSEcCtD
Butabarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—hematologic cancer	0.000202	0.00187	CbGpPWpGaD
Butabarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—hematologic cancer	0.0002	0.00184	CbGpPWpGaD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—PRKCG—hematologic cancer	0.000199	0.00184	CbGpPWpGaD
Butabarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—hematologic cancer	0.000199	0.00184	CbGpPWpGaD
Butabarbital—GRIK2—Transmission across Chemical Synapses—CREB1—hematologic cancer	0.000199	0.00183	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—FOS—hematologic cancer	0.000198	0.00183	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—CREB1—hematologic cancer	0.000198	0.00182	CbGpPWpGaD
Butabarbital—Hypersensitivity—Doxorubicin—hematologic cancer	0.000197	0.000295	CcSEcCtD
Butabarbital—GABRB2—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.000197	0.00181	CbGpPWpGaD
Butabarbital—GRIK2—Transmission across Chemical Synapses—BRAF—hematologic cancer	0.000196	0.00181	CbGpPWpGaD
Butabarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—hematologic cancer	0.000196	0.00181	CbGpPWpGaD
Butabarbital—Vomiting—Methotrexate—hematologic cancer	0.000196	0.000294	CcSEcCtD
Butabarbital—GABRA1—Transmission across Chemical Synapses—CAMK2D—hematologic cancer	0.000195	0.0018	CbGpPWpGaD
Butabarbital—Rash—Methotrexate—hematologic cancer	0.000195	0.000291	CcSEcCtD
Butabarbital—Dermatitis—Methotrexate—hematologic cancer	0.000194	0.000291	CcSEcCtD
Butabarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—hematologic cancer	0.000194	0.00179	CbGpPWpGaD
Butabarbital—Headache—Methotrexate—hematologic cancer	0.000193	0.000289	CcSEcCtD
Butabarbital—GABRG2—Neuronal System—ADCY7—hematologic cancer	0.000192	0.00177	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.000191	0.00177	CbGpPWpGaD
Butabarbital—Dizziness—Epirubicin—hematologic cancer	0.000191	0.000286	CcSEcCtD
Butabarbital—GABRB2—Orphan transporters—CREBBP—hematologic cancer	0.000188	0.00173	CbGpPWpGaD
Butabarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCG—hematologic cancer	0.000188	0.00173	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—PRKCG—hematologic cancer	0.000187	0.00173	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—CAMK2D—hematologic cancer	0.000187	0.00172	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.000186	0.00172	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—MAP2K1—hematologic cancer	0.000184	0.0017	CbGpPWpGaD
Butabarbital—Vomiting—Epirubicin—hematologic cancer	0.000184	0.000275	CcSEcCtD
Butabarbital—GABRA1—Neuronal System—SLC22A1—hematologic cancer	0.000183	0.00169	CbGpPWpGaD
Butabarbital—Nausea—Methotrexate—hematologic cancer	0.000183	0.000274	CcSEcCtD
Butabarbital—Rash—Epirubicin—hematologic cancer	0.000182	0.000273	CcSEcCtD
Butabarbital—Dermatitis—Epirubicin—hematologic cancer	0.000182	0.000272	CcSEcCtD
Butabarbital—CHRNA7—Transmission across Chemical Synapses—CREB1—hematologic cancer	0.000181	0.00167	CbGpPWpGaD
Butabarbital—Headache—Epirubicin—hematologic cancer	0.000181	0.000271	CcSEcCtD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—AR—hematologic cancer	0.00018	0.00166	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—CREB1—hematologic cancer	0.00018	0.00166	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.00018	0.00166	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.00018	0.00166	CbGpPWpGaD
Butabarbital—CHRNA7—Transmission across Chemical Synapses—BRAF—hematologic cancer	0.000179	0.00165	CbGpPWpGaD
Butabarbital—Dizziness—Doxorubicin—hematologic cancer	0.000177	0.000264	CcSEcCtD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—IL6R—hematologic cancer	0.000176	0.00162	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—CREBBP—hematologic cancer	0.000175	0.00162	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—PIK3R1—hematologic cancer	0.000173	0.00159	CbGpPWpGaD
Butabarbital—GABRG2—Orphan transporters—CREBBP—hematologic cancer	0.000172	0.00158	CbGpPWpGaD
Butabarbital—Nausea—Epirubicin—hematologic cancer	0.000172	0.000257	CcSEcCtD
Butabarbital—GABRG2—Neuronal System—CAMK2D—hematologic cancer	0.000171	0.00158	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.000171	0.00157	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.000171	0.00157	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.000171	0.00157	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.000171	0.00157	CbGpPWpGaD
Butabarbital—Vomiting—Doxorubicin—hematologic cancer	0.00017	0.000254	CcSEcCtD
Butabarbital—Rash—Doxorubicin—hematologic cancer	0.000168	0.000252	CcSEcCtD
Butabarbital—Dermatitis—Doxorubicin—hematologic cancer	0.000168	0.000252	CcSEcCtD
Butabarbital—GABRA1—Neuronal System—ADCY7—hematologic cancer	0.000168	0.00155	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—JAK2—hematologic cancer	0.000168	0.00155	CbGpPWpGaD
Butabarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—hematologic cancer	0.000167	0.00154	CbGpPWpGaD
Butabarbital—Headache—Doxorubicin—hematologic cancer	0.000167	0.000251	CcSEcCtD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.000167	0.00154	CbGpPWpGaD
Butabarbital—GRIK2—Transmission across Chemical Synapses—MDM2—hematologic cancer	0.000165	0.00152	CbGpPWpGaD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCG—hematologic cancer	0.000164	0.00151	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—IL1B—hematologic cancer	0.000164	0.00151	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—CASP3—hematologic cancer	0.000163	0.00151	CbGpPWpGaD
Butabarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—hematologic cancer	0.000162	0.0015	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—MTOR—hematologic cancer	0.000159	0.00147	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—JUN—hematologic cancer	0.000159	0.00146	CbGpPWpGaD
Butabarbital—Nausea—Doxorubicin—hematologic cancer	0.000159	0.000238	CcSEcCtD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—HES1—hematologic cancer	0.000159	0.00146	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—IL10—hematologic cancer	0.000158	0.00145	CbGpPWpGaD
Butabarbital—GRIA2—Neuronal System—PRKCG—hematologic cancer	0.000157	0.00145	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.000157	0.00145	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.000156	0.00144	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.000156	0.00144	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.000156	0.00144	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—PRKCG—hematologic cancer	0.000154	0.00142	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.000154	0.00142	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—PRKCG—hematologic cancer	0.000153	0.00141	CbGpPWpGaD
Butabarbital—GRIK2—Neuronal System—CREB1—hematologic cancer	0.000152	0.00141	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—CREB1—hematologic cancer	0.000152	0.0014	CbGpPWpGaD
Butabarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—hematologic cancer	0.000152	0.0014	CbGpPWpGaD
Butabarbital—GRIK2—Neuronal System—BRAF—hematologic cancer	0.00015	0.00139	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—BRAF—hematologic cancer	0.00015	0.00139	CbGpPWpGaD
Butabarbital—GABRA1—Orphan transporters—CREBBP—hematologic cancer	0.00015	0.00138	CbGpPWpGaD
Butabarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—hematologic cancer	0.00015	0.00138	CbGpPWpGaD
Butabarbital—CHRNA7—Transmission across Chemical Synapses—MDM2—hematologic cancer	0.00015	0.00138	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—CAMK2D—hematologic cancer	0.000149	0.00138	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.000149	0.00138	CbGpPWpGaD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—CREB1—hematologic cancer	0.000148	0.00136	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—CASP3—hematologic cancer	0.000146	0.00135	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—EP300—hematologic cancer	0.000146	0.00135	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—NR3C1—hematologic cancer	0.000146	0.00135	CbGpPWpGaD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—BRAF—hematologic cancer	0.000146	0.00134	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—JUN—hematologic cancer	0.000142	0.00131	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—PRKCG—hematologic cancer	0.000141	0.0013	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.00014	0.0013	CbGpPWpGaD
Butabarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—hematologic cancer	0.000139	0.00128	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	0.000139	0.00128	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—CREB1—hematologic cancer	0.000139	0.00128	CbGpPWpGaD
Butabarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—hematologic cancer	0.000137	0.00127	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—BRAF—hematologic cancer	0.000137	0.00126	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.000136	0.00126	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.000136	0.00126	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.000136	0.00126	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.000135	0.00124	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—MAPK8—hematologic cancer	0.000135	0.00124	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—IL1B—hematologic cancer	0.000134	0.00123	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—CASP3—hematologic cancer	0.000133	0.00123	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—JUN—hematologic cancer	0.000129	0.00119	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—SRC—hematologic cancer	0.000128	0.00118	CbGpPWpGaD
Butabarbital—GRIK2—Neuronal System—MDM2—hematologic cancer	0.000126	0.00116	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—MDM2—hematologic cancer	0.000126	0.00116	CbGpPWpGaD
Butabarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—hematologic cancer	0.000126	0.00116	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—PRKCG—hematologic cancer	0.000123	0.00114	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.000123	0.00114	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.000123	0.00114	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—STAT3—hematologic cancer	0.000123	0.00114	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.000123	0.00113	CbGpPWpGaD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—MDM2—hematologic cancer	0.000122	0.00113	CbGpPWpGaD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—hematologic cancer	0.000121	0.00112	CbGpPWpGaD
Butabarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	0.00012	0.00111	CbGpPWpGaD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—hematologic cancer	0.00012	0.00111	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—EP300—hematologic cancer	0.000119	0.0011	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—TNF—hematologic cancer	0.000119	0.0011	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—PRKCG—hematologic cancer	0.000118	0.00109	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—MAPK3—hematologic cancer	0.000118	0.00108	CbGpPWpGaD
Butabarbital—GRIA2—Neuronal System—CREB1—hematologic cancer	0.000117	0.00108	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.000116	0.00107	CbGpPWpGaD
Butabarbital—GRIA2—Neuronal System—BRAF—hematologic cancer	0.000115	0.00106	CbGpPWpGaD
Butabarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—hematologic cancer	0.000115	0.00106	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—MDM2—hematologic cancer	0.000115	0.00106	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—CREB1—hematologic cancer	0.000114	0.00105	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	0.000113	0.00104	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—CREB1—hematologic cancer	0.000113	0.00104	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000113	0.00104	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—BRAF—hematologic cancer	0.000113	0.00104	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.000113	0.00104	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.000112	0.00103	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—BRAF—hematologic cancer	0.000112	0.00103	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—CREB1—hematologic cancer	0.000111	0.00103	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.00011	0.00101	CbGpPWpGaD
Butabarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	0.000109	0.00101	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—IL6R—hematologic cancer	0.000109	0.001	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—CREBBP—hematologic cancer	0.000109	0.001	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—PRKCG—hematologic cancer	0.000108	0.000997	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.000108	0.000994	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.000106	0.000982	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—CREB1—hematologic cancer	0.000104	0.000964	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000103	0.000953	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—BRAF—hematologic cancer	0.000103	0.000952	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.000103	0.000946	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.000101	0.000927	CbGpPWpGaD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—hematologic cancer	0.000101	0.000927	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	9.86e-05	0.000909	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—TFRC—hematologic cancer	9.79e-05	0.000904	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—TNF—hematologic cancer	9.69e-05	0.000894	CbGpPWpGaD
Butabarbital—GRIA2—Neuronal System—MDM2—hematologic cancer	9.64e-05	0.000889	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—IL6—hematologic cancer	9.59e-05	0.000885	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—MDM2—hematologic cancer	9.45e-05	0.000872	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—PRKCG—hematologic cancer	9.45e-05	0.000872	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—MDM2—hematologic cancer	9.35e-05	0.000863	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—NUP98—hematologic cancer	9.3e-05	0.000858	CbGpPWpGaD
Butabarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	9.19e-05	0.000847	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—CREB1—hematologic cancer	9.13e-05	0.000842	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	9.03e-05	0.000833	CbGpPWpGaD
Butabarbital—GRIK2—Transmission across Chemical Synapses—HRAS—hematologic cancer	9.03e-05	0.000833	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—BRAF—hematologic cancer	9.02e-05	0.000832	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—HRAS—hematologic cancer	8.98e-05	0.000828	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—NUP214—hematologic cancer	8.97e-05	0.000827	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—TFRC—hematologic cancer	8.96e-05	0.000826	CbGpPWpGaD
Butabarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	8.91e-05	0.000822	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	8.79e-05	0.00081	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—CREB1—hematologic cancer	8.75e-05	0.000807	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—MDM2—hematologic cancer	8.64e-05	0.000797	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—BRAF—hematologic cancer	8.64e-05	0.000797	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—IL1B—hematologic cancer	8.27e-05	0.000763	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—CASP3—hematologic cancer	8.25e-05	0.000761	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—CYCS—hematologic cancer	8.22e-05	0.000758	CbGpPWpGaD
Butabarbital—CHRNA7—Transmission across Chemical Synapses—HRAS—hematologic cancer	8.22e-05	0.000758	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—JUN—hematologic cancer	8.01e-05	0.000739	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—CREB1—hematologic cancer	8.01e-05	0.000738	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—AKT1—hematologic cancer	7.93e-05	0.000732	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—BRAF—hematologic cancer	7.9e-05	0.000729	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—TFRC—hematologic cancer	7.83e-05	0.000722	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—IL6—hematologic cancer	7.82e-05	0.000721	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—MDM2—hematologic cancer	7.56e-05	0.000697	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—CYCS—hematologic cancer	7.52e-05	0.000694	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—EP300—hematologic cancer	7.39e-05	0.000682	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—MDM2—hematologic cancer	7.24e-05	0.000668	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	7e-05	0.000646	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—CREB1—hematologic cancer	7e-05	0.000645	CbGpPWpGaD
Butabarbital—GRIK2—Neuronal System—HRAS—hematologic cancer	6.92e-05	0.000638	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—BRAF—hematologic cancer	6.91e-05	0.000637	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—HRAS—hematologic cancer	6.91e-05	0.000637	CbGpPWpGaD
Butabarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	6.9e-05	0.000636	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	6.86e-05	0.000633	CbGpPWpGaD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—HRAS—hematologic cancer	6.7e-05	0.000618	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—MDM2—hematologic cancer	6.62e-05	0.000611	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—CYCS—hematologic cancer	6.57e-05	0.000606	CbGpPWpGaD
Butabarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	6.31e-05	0.000582	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—HRAS—hematologic cancer	6.29e-05	0.000581	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	6.27e-05	0.000579	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—TNF—hematologic cancer	6e-05	0.000553	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—MDM2—hematologic cancer	5.79e-05	0.000534	CbGpPWpGaD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	5.52e-05	0.000509	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	5.48e-05	0.000506	CbGpPWpGaD
Butabarbital—GRIA2—Neuronal System—HRAS—hematologic cancer	5.29e-05	0.000488	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—HRAS—hematologic cancer	5.19e-05	0.000478	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—HRAS—hematologic cancer	5.13e-05	0.000473	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—IL6—hematologic cancer	4.84e-05	0.000447	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—HRAS—hematologic cancer	4.74e-05	0.000438	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	4.58e-05	0.000423	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—ALB—hematologic cancer	4.29e-05	0.000396	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	4.19e-05	0.000387	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—HRAS—hematologic cancer	4.15e-05	0.000382	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—HRAS—hematologic cancer	3.97e-05	0.000367	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—ALB—hematologic cancer	3.92e-05	0.000362	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.66e-05	0.000338	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—HRAS—hematologic cancer	3.63e-05	0.000335	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—ALB—hematologic cancer	3.43e-05	0.000316	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—HRAS—hematologic cancer	3.18e-05	0.000293	CbGpPWpGaD
